Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: An interim analysis

被引：1
|
作者：
Takahara, Naminatsu
Isayama, Hiroyuki
Nakai, Yousuke
Sasaki, Takashi
Ishigami, Hironori
Yamaguchi, Hironori
Kogure, Hirofumi
Yamamoto, Natsuyo
Hirano, Naoki Sasahira Kenji
Tada, Minoru
Kitayama, Joji
Watanabe, Toshiaki
Koike, Kazuhiko
机构：
[1] Kanto Cent Hosp, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[3] Univ Tokyo, Tokyo, Japan
[4] Univ Tokyo, Dept Outpatient Chemotherapy, Tokyo, Japan
[5] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan
[6] Senpo Tokyo Takanawa Hosp, Tokyo, Japan
[7] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo, Japan
[8] Univ Tokyo, Fac Med, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.267
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
267
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: an interim analysis
    Takahara N.
    Isayama H.
    Nakai Y.
    Sasaki T.
    Ishigami H.
    Yamashita H.
    Yamaguchi H.
    Hamada T.
    Uchino R.
    Mizuno S.
    Miyabayashi K.
    Mohri D.
    Kawakubo K.
    Kogure H.
    Yamamoto N.
    Sasahira N.
    Hirano K.
    Ijichi H.
    Tateishi K.
    Tada M.
    Kitayama J.
    Watanabe T.
    Koike K.
    Journal of Gastrointestinal Cancer, 2014, 45 (3) : 307 - 311
  • [2] Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites
    Takahara, Naminatsu
    Isayama, Hiroyuki
    Nakai, Yousuke
    Ishigami, Hironori
    Satoi, Sohei
    Mizuno, Suguru
    Kogure, Hirofumi
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Yamaguchi, Hironori
    Tada, Minoru
    Kitayama, Joji
    Watanabe, Toshiaki
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (05) : 636 - 642
  • [3] Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites
    Naminatsu Takahara
    Hiroyuki Isayama
    Yousuke Nakai
    Hironori Ishigami
    Sohei Satoi
    Suguru Mizuno
    Hirofumi Kogure
    Saburo Matsubara
    Natsuyo Yamamoto
    Hironori Yamaguchi
    Minoru Tada
    Joji Kitayama
    Toshiaki Watanabe
    Kazuhiko Koike
    Investigational New Drugs, 2016, 34 : 636 - 642
  • [4] Weekly Intravenous and Intraperitoneal Paclitaxel Combined With S-1 for Gemcitabine-Refractory Pancreatic Cancer With Malignant Ascites: An Interim Analysis
    Takahara, N.
    Isayama, H.
    Nakai, Y.
    Sasaki, T.
    Ishigami, H.
    Yamashita, H.
    Yamaguchi, H.
    Mizuno, S.
    Kogure, H.
    Yamamoto, N.
    Hirano, K.
    Tada, M.
    Kitayama, J.
    Watanabe, T.
    Koike, K.
    PANCREAS, 2012, 41 (07) : 1159 - 1159
  • [5] Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Malignant Ascites due to Advanced Gastric Cancer
    Kitayama, Joji
    Ishigami, Hironori
    Kaisaki, Shoichi
    Hidemura, Akio
    Kato, Masahiro
    Otani, Kensuke
    Kamei, Takao
    Soma, Daisuke
    Miyato, Hideyo
    Yamashita, Hiroharu
    Nagawa, Hirokazu
    ONCOLOGY, 2010, 78 (01) : 40 - 46
  • [6] Combined chemotherapy of intravenous and intraperitoneal paclitaxel with S-1 for malignant ascites due to advanced gastric cancer with peritoneal dissemination
    Kitayama, J.
    Ishigami, H.
    Kaisaki, S.
    Hidemura, A.
    Kato, M.
    Nagawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Intravenous and intraperitoneal paclitaxel with S-1: new hope for patients with pancreatic cancer and peritoneal metastases?
    Niesen, Willem
    Strobel, Oliver
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S716 - S721
  • [8] Conversion therapy for pancreatic cancer with peritoneal metastases using intravenous and intraperitoneal paclitaxel with S-1
    Kitayama, Hiromitsu
    Tsuji, Yasushi
    Kondo, Tomohiro
    Sugiyama, Junko
    Hirayama, Michiaki
    Yamamoto, Kazuyuki
    Kawarada, You
    Oyamada, Yumiko
    Hirano, Satoshi
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (06) : 779 - 782
  • [9] Intraperitoneal nivolumab in a patient with pancreatic cancer and refractory malignant ascites
    Wang, Sing-Ting
    Chiu, Chang-Fang
    Bai, Hui-Jen
    Bai, Li-Yuan
    EUROPEAN JOURNAL OF CANCER, 2021, 148 : 48 - 50
  • [10] Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites
    Joji Kitayama
    Hironori Ishigami
    Hironori Yamaguchi
    Hiroharu Yamashita
    Shigenobu Emoto
    Shoich Kaisaki
    Toshiaki Watanabe
    Annals of Surgical Oncology, 2014, 21 : 539 - 546
12345